Description
Benefits
- Supports both central (arousal) and peripheral (blood flow) aspects of sexual function
- May support enhanced libido, initiation, and erectile response
- Promotes stronger, fuller erections through nitric oxide–mediated vasodilation
- Combines long-acting and fast-acting PDE5 inhibition for layered effects
- Sublingual delivery allows for faster onset and improved absorption
- Commonly used in advanced, on-demand sexual performance protocols
Background and History
- Apomorphine is a dopamine agonist historically studied for its role in sexual function and neurological signaling pathways
- PDE5 inhibitors like Tadalafil and Vardenafil are well-established treatments for erectile dysfunction with extensive clinical use
- Tadalafil is known for its longer half-life, providing sustained effects, while Vardenafil offers a more rapid and potent onset
- Combination approaches targeting both central and peripheral pathways are increasingly used in performance-focused protocols
- Sublingual delivery systems are utilized to bypass first-pass metabolism and improve onset time
- These compounds are prescribed under provider oversight in sexual health and performance optimization settings
Compounded, non-FDA-approved medication. Individual results may vary.
